Not checked for notices yet.

Streptomyces as a Prominent Resource of Future Anti-MRSA Drugs

Hefa Mangzira Kemung, Hefa Mangzira Kemung, Loh Teng-Hern Tan and 15 more

Frontiers in Microbiology · 2018

doi:10.3389/fmicb.2018.02221

Cited by papers we hold 2

Streptomyces: The biofactory of secondary metabolites · 2022
No notice
The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis · 2020
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.